HCP HashiCorp, Inc. Insider Trading

HashiCorp CTO Armon sold 17,800 shares at $34.23 on 2024-12-24; stock near 52-week high of $34.27.

Dadgar Armon, Chief Technology Officer, sold 17,800 shares (17.8K shares) at $34.23, reducing his holdings by -36.2% from 49,148 shares to 31,348 shares. The sale occurred near the 52-week high of $34.27, with the current price at $34.18 (-0.3% from that peak). At the same-ticker level, Armon has executed 5 prior sells at HCP over recent months (2024-10-02 through 2024-12-02), with measurable 30-day outcomes showing minimal impact (+0.2%, +0.1%, -0.8%, +1.1%, and one pending). The company remains unprofitable on a full-year basis (net income: $-13.0M) despite quarterly revenue of $173.4M and annual growth of +22.5%. This sale represents a material reduction in the insider's equity stake at a price near peak recent levels, without evidence of sustained well-timed exit patterns at this ticker.

CEO David McJannet sold 47,526 shares of HCP at $34.22 on 2024-12-20, reducing holdings 9.3% to 466.0K shares

CEO David McJannet executed a sale of 47,526 shares at $34.22, reducing his position by 9.3% to 465,978 shares post-transaction. This sale occurs near HashiCorp's 52-week high of $34.27, with the stock at $34.24 current price and showing modest positive momentum (+1.2% over 90 days). However, this trade represents a partial reduction from a significant CEO stake, not a full position exit—the filing indicates derivative securities holdings in Form 4 Table II that are not yet populated in the database, meaning the stated 466.0K shares do not represent the insider's total position. Critically, McJannet's prior sell history at HCP shows weak timing execution: across 5 prior sales at this ticker, none achieved positive returns at the 90-day mark, suggesting a pattern of selling at inopportune moments despite the company's 22.5% annual revenue growth. The company remains unprofitable (net income of $-13.0M), which may explain the cautious stance, but the timing track record warrants attention.

CTO Armon sells 35,903 HCP shares at $33.58 on 2024-12-02; retains 1,520,000 shares post-sale

CTO Dadgar Armon sold 35,903 shares of HashiCorp at $33.58, reducing his position by 2.3% to 1,520,000 shares retained. This sale occurs while the stock is near its 52-week high of $34.08 and as the company remains unprofitable with a net loss of $26,462,000 on trailing revenue of $165,138,000. Notably, this represents the insider's fifth consecutive sale at HCP within a span of roughly 2 months (prior sells on 2024-11-22, 2024-11-04, 2024-10-22, and 2024-10-02), establishing a consistent pattern of incremental reductions rather than a single or isolated disposition. The FLAG notes this involves a derivative conversion; the Table I shares_after figure should not be read as the insider's complete equity stake, as derivative holdings tracked in Table II are not yet populated in the database.

CTO Dadgar Armon sold 35,903 shares of HCP at $33.90 on 2024-11-22; retains 1,520,000 shares post-transaction.

Armon sold 35,903 shares at $33.90, reducing his holdings by 2.3% but maintaining a substantial 1,520,000 share position post-transaction. The sale occurred near the 52-week high ($34.08), with the current price at $33.92, suggesting execution near peak valuation. His prior five sales at HCP span September through November 2024 with mixed short-term outcomes (-0.4% to +0.2% on 30-day measures), and measurable 90-day results remain pending for all recent trades. Against his cross-ticker track record (20 prior sells, 7.69% well-timed rate with +9.6% average 90-day return), this represents a modest continuation of recent selling activity rather than a material position reduction.

HashiCorp CTO Dadgar sold 35,904 shares at $33.86; retains 1,520,000 shares post-transaction.

Armon Dadgar, CTO of HashiCorp, sold 35,904 shares on 2024-11-04 at $33.86, reducing holdings from 1.56M to 1.52M shares (a -2.3% reduction). The current stock price of $33.85 sits near the 52-week high of $33.99, within -0.4% of peak levels. This transaction occurs in the context of a company that generated $165.1M in quarterly revenue with +22.5% annual growth, but reported a net loss of $26.5M in the most recent quarter and remains unprofitable on a full-year basis. Dadgar's cross-ticker track record shows 20 prior open-market sells with an average 90-day return of +12.1% and a well-timed rate of 0.00%, indicating his sales have historically been followed by stock price increases rather than declines. At this specific ticker (HCP), his five prior sales—all clustered in late September and early October 2024—have similarly shown neutral or slightly positive returns in the 30-day window, with no measurable 90-day outcomes yet available. The sale is classified as a derivative-conversion transaction and does not represent the insider's full position, which has additional holdings in derivative securities not yet reflected in the database.

HashiCorp CTO Armon Dadgar sells 35,904 shares at $33.82; retains 1.52M shares amid unprofitable fundamentals

Dadgar sold 35,904 shares for $1,214,280.46, representing a -2.3% reduction of his holdings to 1.52M shares. The sale occurred at $33.82, near the 52-week high of $33.99, and follows four other sales at HCP since September 3, 2024, indicating a sustained pattern of share reductions. HashiCorp's latest quarterly revenue of $165.1M is growing at +22.5% year-over-year, but the company reported a net loss of $26.5M in the quarter and remains unprofitable on a full-year basis, creating tension between revenue momentum and operational losses. Dadgar's cross-ticker track record shows 20 prior sells with a 0.00% well-timed rate at the 90-day mark (average 90d return +16.1%), meaning prior sales occurred before stock gains—not a pattern that supports well-timed market exits.

CTO Dadgar Armon sold 35,904 shares of HashiCorp at $33.84; retains 1.52M shares post-sale

Armon sold 35,904 shares on 2024-10-02 at $33.84, reducing his holdings by -2.3% to 1,520,000 shares. This sale occurs amid a series of recent HCP transactions by the same insider (five trades since August 22, 2024), though outcome data for the three most recent sales remain unmeasurable. The company reported unprofitable operations (net income: $-26,462,000.00) despite solid annual revenue growth of +22.5% to $165,138,000.00; this unprofitability context frames the sale against HashiCorp's operational losses. The current stock price of $33.88 is -0.3% from the 52-week high ($33.99) and closely tracks the transaction price, placing the sale near peak valuation levels. No evidence of derivative-position context is currently available in the database for this filing.

CTO Dadgar Armon sold 53,563 shares for $1,810,761.91 at blended avg $33.81

Dadgar Armon, Chief Technology Officer of HashiCorp, conducted two separate open-market sales totaling 53,563 shares for $1,810,761.91 at a blended average price of $33.81, reducing his post-transaction holdings to 27,275 shares (a -66.3% reduction vs pre-transaction holdings of 80,838 shares). The sale prices ($33.80–$33.81) align closely with the current price of $33.84, near the 52-week high of $33.99, suggesting execution at elevated valuation levels. However, the company remains unprofitable with net income of $-26,462,000.00 against revenue of $165,138,000.00, though it achieved annual revenue growth of +22.5%. A material FLAG notes this filing involves a derivative-conversion transaction, meaning the Table I shares_after (27,275) do not represent the insider's total position; the full position lives in Table II (derivative securities), not yet populated in the database, so the economic significance of this partial sale cannot be assessed in isolation.

HCP President St. Ledger Susan sold 22,232 shares at $33.84; stock flat near 52-week high at $33.82.

Susan St. Ledger, President of Worldwide Field Ops, sold 22,232 shares (22.2K shares) for $752,346.44 on 2024-09-20, reducing her holdings by 11.7% from 189,979 shares to 167,747 shares. The sale occurred at $33.84, within 0.5% of the 52-week high of $33.99, with the stock currently at $33.82. Across her two prior sales at HashiCorp, only 1 of 2 proved well-timed at the 90-day mark (her 2023-09-21 sale declined 1.6% over 90 days, but her June 2024 sale gained 2.0%). Meanwhile, HashiCorp remains unprofitable with net income of -$26.5M on revenue of $165.1M, though the company posted 22.5% annual revenue growth. The sale size is material but not unprecedented for an executive at this company level, and occurs at historically favorable price levels rather than indicating distress.

CEO David McJannet sold 48,055 shares of HCP at $33.84; still holds 419,531 shares post-transaction.

David McJannet, CEO and Chairman, sold 48,055 shares at $33.84 on 2024-09-20 for $1,626,214.84, representing a 10.3% reduction of his pre-transaction stake of 467,586 shares. This sale occurs near the 52-week high of $33.99 (-0.5% from peak) and follows a pattern in his HCP-specific history: of 5 prior sells at this ticker, only 1 demonstrated favorable 90-day timing. His cross-ticker track record shows 6 prior sells with a 90-day well-timed rate of 33.33%, suggesting mixed execution overall. The sale is notable given the company's fundamental position—HashiCorp posted $165.1M in revenue with annual growth of 22.5%, yet reported a net loss of $26.5M in the latest quarter and remains unprofitable on a full-year basis. The transaction is a derivative conversion event; the insider's complete position including unconverted derivatives is not fully visible in current database records, so this should be assessed as a partial sale of a specific batch rather than a broader position shift.